Autistic Effect - Search News

FDA approves generic drug for a rare genetic condition

US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms

The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children with the much broader diagnosis...

· 1d

The FDA approves leucovorin for rare genetic condition and not for autism

· 1d

FDA Approves Drug for Rare Brain Disorder, Not Autism

· 1d

FDA won’t endorse Leucovorin for autism

The FDA expanded the use of prescription drug Leucovorin, but said it won’t recommend it for autism.

· 1d

FDA OKs drug for rare brain disorder

· 1d

RFK Jr.’s Autism Drug Claims Face Pushback From FDA — Report

FDA finds little evidence that a drug touted by Trump can help people with autism

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.

‘Betrayed’: Families are dealing with dashed hopes after pivot on autism treatment

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they feel abandoned by the US Food and Drug Administration’s new stance on leucovorin.

10don MSN

A closer look at the mathematical abilities of autistic people

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in how people learn, communicate and interact with others, as well as restrictive or repetitive behaviors.

Hosted on MSN

Autistic employees are less susceptible to the Dunning-Kruger effect

A study involving participants in Canada and the U.S. found that autistic employees are less susceptible to the Dunning–Kruger effect than their non-autistic peers. After completing a cognitive reflection task, autistic participants estimated their own ...

2don MSN

FDA approves leucovorin for rare genetic condition, but not for autism

The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when officials touted the drug as a potential treatment for thousands of children with autism.